New Evidence Supporting the SHAPE Screening and Polypill Awareness Campaigns (ACC 2009 Highlights)

New Evidence Supporting the SHAPE Screening and Polypill Awareness Campaigns from the Annual Scientific Sessions of the American College of Cardiology

Houston, TX (PRWEB) April 7, 2009 -- New evidence supporting the SHAPE Screening and Polypill Awareness Campaigns from the Annual Scientific Sessions of the American College of Cardiology. The following are research highlights from ACC 2009:

* Heinz Nixdorf Recall Study (HNR) illustrates Coronary Artery Calcium Score as a strong predictor of cardiovascular events beyond traditional risk factors. Follow the link to download the PowerPoint presentation: http://www.aehamovieholder.com/PowerPoints/Heinz_Nixdorf_Erbel.ppt

* The Indian Polycap Study (TlPS) investigators examine the effects of a Polycap (polypill) cocktail that could reduce multiple risk factors and cardiovascular risk in healthy, middle-aged individuals. Follow the link to read the Abstract: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)60611-5/fulltext

The following are latest updates from SHAPE:

* Good Morning America's Diane Sawyer and GMA medical contributor, Dr. Marie Savard, give Americans the wake up call regarding the significance of testing for asymptomatic atherosclerosis for early detection and prevention of heart attacks in asymptomatic vulnerable patients. Dr. Savard presented two cases, a 45y old male and a 55y old female resembling the SHAPE guideline. Click the link to view Video On Demand from Good Morning America: http://abcnews.go.com/Video/playerIndex?id=7206382

* SHAPE and Peggy Fleming for KanekaQH's "Heart 365" campaign appeared on CBS Channel 11's Great Day Houston with Debra Duncan to promote heart health awareness and the importance of non-invasive heart screening for early detection, prevention, and treatment of heart attack. SHAPE appreciates the generous contribution of KanekaQH for the SHAPE Heart Attack Prevention Campaign. Click the link to view Video on Demand From Great Day Houston: http://www.khou.com/greatday/video/?nvid=345000&shu=1

* Click the link to view SHAPE's previous press release: http://www.shapesociety.org/SHAPE_Raises_Heart_Attack_Awareness_on_CBS_Channel_11/

* To learn more about the mission of SHAPE, follow the link: http://www.shapesociety.org/Mission_of_SHAPE_Illustrated/

* Click the link to view SHAPE's illustration of "A Path Towards Eradicating Heart Attack": http://www.shapesociety.org/files/about/the_mission_of_shape/image008.gif

Reference: Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK; SHAPE Task Force.

Am J Cardiol. 2006 Jul 17;98(2A):2H-15H. Epub 2006 Jun 12.

About SHAPE:

Originated from the Texas Medical Center in Houston, the Society for Heart Attack Prevention and Eradication (SHAPE) is a non-profit organization founded by Dr. Morteza Naghavi, a former faculty of the Texas Heart Institute and the University of Texas in Houston. The mission of SHAPE is to promote education and research related to mechanism, prevention, detection, and treatment of heart attacks. The organization is committed to raising public awareness about recent revolutionary discoveries that opened exciting new avenues to prevent heart attack. The SHAPE's mission is to eradicate heart attacks in the 21st century. Additional information is available on the organization's Web site at http://www.shapesociety.org.

About SHAPE Task Force:

Chairman: Morteza Naghavi, M.D. Editorial Committee: Prediman K. Shah, M.D. (Chief); (alphabetic order): Raymond Bahr, M.D., Daniel Berman, M.D., Roger Blumenthal, M.D., Matthew J. Budoff, M.D., Jay Cohn, M.D., Erling Falk, M.D., Ph.D., Ole Faergeman, M.D., Zahi Fayad, Ph.D., Harvey S. Hecht, M.D., Wolfgang Koenig, M.D., Ph.D., Daniel Lane, M.D., Ph.D., Morteza Naghavi, M.D., John Rumberger, M.D., Ph.D., Allen J. Taylor, M.D. Writing Group: Erling Falk, M.D., Ph.D. (Coordinator); (alphabetic order): Juhani Airaksinen, M.D., Dan Arking, Ph.D., Juan Badimon, Ph.D., Raymond Bahr, M.D., Daniel Berman, M.D., Matthew J. Budoff, M.D., Jay Cohn, M.D., Jasenka Demirovic, M.D., Ph.D., George A. Diamond, M.D., Pamela Douglas, M.D., Ole Faergeman, M.D., Zahi Fayad, Ph.D., James A. Goldstein, M.D., Harvey S. Hecht, M.D., Victoria L.M. Herrera, M.D., Sanjay Kaul, M.D., M.P.H., Wolfgang Koenig, M.D., Ph.D., Robert A. Mendes, M.D., Morteza Naghavi, M.D.; Tasneem Z. Naqvi, M.D., Ward A. Riley, Ph.D., Yoram Rudy, PhD, John Rumberger, M.D., Ph.D., Leslee Shaw, Ph.D., Robert S. Schwartz, M.D., Arturo G. Touchard, M.D. Advisors (alphabetic order): Arthur Agagston, M.D., Stephane Carlier, M.D., Ph.D., Raimund Erbel, M.D., Chris deKorte, Ph.D., Craig Hartley, Ph.D., Ioannis Kakadiaris, Ph.D., Roxana Mehran, M.D., Ralph Metcalfe, Ph.D., Daniel O'Leary, M.D., Jan Nilsson, M.D., Gerard Pasterkamp, M.D., Ph.D., Paul Schoenhagen, M.D., Henrik Sillesen, M.D., Ph.D.

###